dc.contributor.author |
Cordier, Werner
|
|
dc.date.accessioned |
2022-07-29T07:00:41Z |
|
dc.date.available |
2022-07-29T07:00:41Z |
|
dc.date.issued |
2021-08 |
|
dc.description.abstract |
Hand hygiene practices have been bolstered during the COVID-19 pandemic to curb the spread of SARS-CoV-2. Unfortunately, such prevention
strategies come with a risk of excessive physical damage to the skin and exposure to dermatological irritants, including soap, alcohol, and
surfactants. Irritant contact dermatitis frequency has increased not only among those typically susceptible to it, such as healthcare workers,
but also among the general populace. This report briefly discusses some of the most common implicated irritants, as well as guidelines and
measures for mitigating dermatitis, which include dermatological treatments ranging from moisturisers to pharmacotherapy. Hand hygiene
practices may not change, but by following good preventative guidelines and appropriate pharmacotherapeutic interventions, irritant
contact dermatitis can be controlled. |
en_US |
dc.description.department |
Pharmacology |
en_US |
dc.description.uri |
http://www.sapj.co.za |
en_US |
dc.identifier.citation |
Cordier, W. 2021, 'Irritant contact dermatitis during COVID-19 : preventing the virus while keeping the itch at bay', SA Pharmaceutical Journal, vol. 88, no. 4, pp.24-28, doi : 10.520/ejc-mp_sapj_v88_n4_a7. |
en_US |
dc.identifier.issn |
2221-5875 (print) |
|
dc.identifier.issn |
2220-1017 (online) |
|
dc.identifier.other |
10.520/ejc-mp_sapj_v88_n4_a7 |
|
dc.identifier.uri |
https://repository.up.ac.za/handle/2263/86583 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Medpharm Publications |
en_US |
dc.rights |
© Medpharm. This article is licensed under a This article is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.5 South Africa License. |
en_US |
dc.subject |
Irritant contact dermatitis |
en_US |
dc.subject |
Moisturisers |
en_US |
dc.subject |
Topical calcineurin inhibitors |
en_US |
dc.subject |
Topical corticosteroids |
en_US |
dc.subject |
COVID-19 pandemic |
en_US |
dc.subject |
Coronavirus disease 2019 (COVID-19) |
en_US |
dc.subject |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
en_US |
dc.title |
Irritant contact dermatitis during COVID-19 : preventing the virus while keeping the itch at bay |
en_US |
dc.type |
Article |
en_US |